Anne Galy

Title: The Innovative Contributions of Anne Galy

Introduction

Anne Galy is a prominent inventor based in Fontainebleau, France. She has made significant contributions to the field of gene therapy through her innovative research and inventions. Her work focuses on the development of stable pseudotyped lentiviral particles, which have important applications in medical science.

Latest Patents

Anne Galy holds a patent for "Stable pseudotyped lentiviral particles and uses thereof." This invention relates to a method for obtaining stable pseudotyped lentiviral particles that include a heterologous gene of interest. The process involves transfecting appropriate cell lines with plasmids containing the gene of interest, along with retroviral genes. The transfected cells are then incubated to produce the lentiviral particles, which can be harvested and concentrated. This method is particularly useful for transducing immune cells and has applications in gene therapy.

Career Highlights

Throughout her career, Anne Galy has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université d'Évry-Val-d'Essonne. Her research has contributed to advancements in the understanding and application of lentiviral vectors in therapeutic settings.

Collaborations

Anne Galy has collaborated with various research institutions and companies to further her work in gene therapy. These collaborations have enhanced the impact of her inventions and have facilitated the translation of her research into practical applications.

Conclusion

Anne Galy's innovative work in the field of gene therapy, particularly her development of stable pseudotyped lentiviral particles, showcases her significant contributions to medical science. Her research continues to pave the way for advancements in therapeutic techniques.